270 related articles for article (PubMed ID: 30885163)
1. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of advanced lung cancer inflammation index in patients with colorectal cancer liver metastases undergoing surgery.
Pian G; Hong SY; Oh SY
Tumori; 2022 Feb; 108(1):56-62. PubMed ID: 33393453
[TBL] [Abstract][Full Text] [Related]
3. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
5. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients with Pathological Stage IA Lung Adenocarcinoma Following Surgical Resection.
Kobayashi S; Karube Y; Inoue T; Araki O; Maeda S; Matsumura Y; Chida M
Ann Thorac Cardiovasc Surg; 2019 Apr; 25(2):87-94. PubMed ID: 30333361
[TBL] [Abstract][Full Text] [Related]
6. Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
Ozyurek BA; Ozdemirel TS; Ozden SB; Erdoğan Y; Ozmen O; Kaplan B; Kaplan T
Clin Respir J; 2018 Jun; 12(6):2013-2019. PubMed ID: 29356383
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of a novel index of nutrition and inflammation for patients with acute decompensated heart failure.
Maeda D; Kanzaki Y; Sakane K; Ito T; Sohmiya K; Hoshiga M
Heart Vessels; 2020 Sep; 35(9):1201-1208. PubMed ID: 32219523
[TBL] [Abstract][Full Text] [Related]
8. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
Tomita M; Ayabe T; Nakamura K
Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
[TBL] [Abstract][Full Text] [Related]
9. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
10. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.
Jafri SH; Shi R; Mills G
BMC Cancer; 2013 Mar; 13():158. PubMed ID: 23530866
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Significance of the Advanced Lung Cancer Inflammation Index (ALI) in Patients with Melanoma Treated with Immunotherapy as Second-Line Therapy.
Cheng X; Dong Y; Lou F
Cancer Manag Res; 2021; 13():173-180. PubMed ID: 33469361
[TBL] [Abstract][Full Text] [Related]
13. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
Kim EY; Kim N; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH
PLoS One; 2016; 11(10):e0164056. PubMed ID: 27706243
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer.
Ikeguchi M; Urushibara S; Shimoda R; Yamamoto M; Maeta Y; Ashida K
World J Surg Oncol; 2014 Jul; 12():210. PubMed ID: 25022764
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
[TBL] [Abstract][Full Text] [Related]
18. The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy.
Horino T; Tokunaga R; Miyamoto Y; Hiyoshi Y; Akiyama T; Daitoku N; Sakamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2023 Mar; 28(3):400-408. PubMed ID: 36637609
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab.
Artaç M; Uysal M; Karaağaç M; Korkmaz L; Er Z; Güler T; Börüban MC; Bozcuk H
J Gastrointest Cancer; 2017 Jun; 48(2):176-180. PubMed ID: 27714653
[TBL] [Abstract][Full Text] [Related]
20. The relation between inflammation-based parameters and survival in metastatic pancreatic cancer.
Turker S; Cilbir E; Guven DC; Karacin C; Yalcin S
J Cancer Res Ther; 2021; 17(2):510-515. PubMed ID: 34121700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
